Form 4: National Healthcare Corp. Executive Exercises Stock Options, Sells Shares to Cover Costs
SEC Form 4
Senior VP & CIO of National Healthcare Corp., Ben Anderson Flatt, Sr., exercised stock options and sold shares to cover the exercise price and tax obligations.
Summary
- On March 12, 2024, Ben Anderson Flatt, Sr., Senior VP & CIO of National Healthcare Corp (NHC), exercised stock options to acquire 3,733 shares of common stock at a price of $53.94 per share.
- Simultaneously, Flatt disposed of 2,620 shares to cover the exercise price and withholding tax obligations at a price of $96.48 per share.
- Following these transactions, Flatt directly owns 12,090.1586 shares of NHC common stock.
- Flatt also holds options to purchase 7,467 shares at $53.94, and 12,000 shares at $94.1.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of insider transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Executives often receive stock options as part of their compensation packages, and their exercise and subsequent sale of shares are closely monitored by regulators and investors.
Comparison to Industry Standards
- Executive compensation packages including stock options are standard practice across the healthcare industry.
- Companies like Brookdale Senior Living and Life Care Centers of America also utilize stock options as part of their executive compensation plans.
- The specific terms of these option grants (exercise price, vesting schedule, etc.) are typically benchmarked against peer companies to ensure competitiveness.
Stakeholder Impact
- The transaction has a minimal direct impact on shareholders, employees, customers, suppliers, and creditors.
- It provides transparency into executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 02/18/2023 | Date of previous option grant with an exercise price of $63.96 and an expiration date of 02/18/2027. |
| 03/08/2023 | Date of grant of the stock options exercised on 03/12/2024. |
| 03/12/2024 | Date of transaction: exercise of stock options and sale of shares. |
| 03/14/2024 | Date of Form 4 filing. |
| 03/05/2025 | Date of option grant with an exercise price of $94.1 and an expiration date of 03/05/2029. |
| 02/18/2027 | Expiration date of previous option grant with an exercise price of $63.96. |
| 03/08/2028 | Expiration date of the stock options exercised on 03/12/2024. |
| 03/05/2029 | Expiration date of option grant with an exercise price of $94.1. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.